GE has awarded Etihad Airways its TRUEngine designation for its GE-CF6-powered Airbus A330 aircraft.
“Etihad is a great customer, and we are very pleased to welcome them to the TRUEngine program,” said Kevin McAllister, President and CEO of GE Aviation’s services organization. “We are committed to providing significant benefits to Etihad, included optimized product support, enhanced warranties and asset value protection.”
“We are pleased to receive the TRUEngine designation from GE, which supports our commitment to optimise performance and reliability of our engines, as well as enhance marketability of our assets,” said James Hogan, President and Chief Executive Officer of Etihad Airways.
Launched in 2008 for the CFM56 engine, the TRUEngine designation provides assurance to owners, operators, and engine buyers that engines qualified as TRUEngine have been maintained in the OEM configuration. The program has since been expanded to include CF6, GEnx and CF34 engines. Independent studies show that engines maintained with OEM parts and repairs maintain as much as 50% higher resale values compared to engines that include non-OEM parts or repairs. Nearly 9,000 engines operated by more than 130 operators have received the TRUEngine designation.
To qualify for TRUEngine status, the engine configuration, overhaul practices, spare parts and repairs used to service an engine must comply with GE-issued engine manuals and other maintenance recommendations. The qualification is obtained through the customer’s declaration of compliance and GE’s verification of customer submitted maintenance records. The TRUEngine designation enhances marketability and provides other valuable benefits at no additional cost, such as extended new part warranty, complimentary access to engine lease pool and optimized product support. For more information, visit www.geaviation.com/services/truengine-program.
For further information, contact:
Rick Kennedy +1.513.243.3372
Deb Case +1.513.243.0094
Saturday, July 19- 2014 @ 14:20 UAE local time (GMT+4) Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of Mediaquest FZ LLC.